A randomized phase II evaluation of weekly gemcitabine plus pazopanib versus weekly gemcitabine alone in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinoma.

Saved in:
Bibliographic Details
Title: A randomized phase II evaluation of weekly gemcitabine plus pazopanib versus weekly gemcitabine alone in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinoma.
Authors: Duska LR; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of Virginia School of Medicine, Charlottesville, VA, USA. Electronic address: lduska@virginia.edu., Petroni GR; Public Health Sciences, University of Virginia School of Medicine, Charlottesville, VA, USA., Varhegyi N; Public Health Sciences, University of Virginia School of Medicine, Charlottesville, VA, USA., Brown J; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Levine Cancer Institute, Charlotte, NC, USA., Jelovac D; Department of Medicine, Division of Medical Oncology. Johns Hopkins University, Baltimore, MD, USA., Moore KN; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA., McGuire WP; Virginia Commonwealth University, Richmond, VA, USA., Darus C; Maine Medical Center, Portland, ME, USA., Barroilhet LM; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology. Univeristy of Wisconsin, Madison, WI, USA., Secord AA; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology. Duke Unviersity Medical Center, Durham, NC, USA.
Source: Gynecologic oncology [Gynecol Oncol] 2020 Jun; Vol. 157 (3), pp. 585-592. Date of Electronic Publication: 2020 Apr 01.
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Academic Press Country of Publication: United States NLM ID: 0365304 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-6859 (Electronic) Linking ISSN: 00908258 NLM ISO Abbreviation: Gynecol Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1095-6859
DOI:10.1016/j.ygyno.2019.10.014